Exclusive

Publication

Byline

Location

US Patent Issued to Beijing Innocare Pharma Tech on Aug. 25 for "Heterocyclic compound as BCL-2 inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,870, issued on Aug. 25, was assigned to Beijing Innocare Pharma Tech Co. Ltd. (Beijing). "Heterocyclic compound as BCL-2 inhibitor" was inv... Read More


US Patent Issued to SHANGHAI RINGENE BIOPHARMA on Aug. 25 for "Aromatic ring-lactam compound, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,871, issued on Aug. 25, was assigned to SHANGHAI RINGENE BIOPHARMA Co. LTD. (Shanghai). "Aromatic ring-lactam compound, preparation method ... Read More


US Patent Issued to Cambridge Enterprise on Aug. 25 for "Benzo[c[2,6naphthyridine derivatives, compositions and therapeutic uses thereof" (British Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,872, issued on Aug. 25, was assigned to Cambridge Enterprise Ltd. (Cambridge, Great Britain). "Benzo[c[2,6naphthyridine derivatives, compos... Read More


US Patent Issued to BroadenBio on Aug. 25 for "Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,873, issued on Aug. 25, was assigned to BroadenBio Co. Ltd. (Beijing). "Pyrazolopyridazinone compound, and pharmaceutical composition and u... Read More


US Patent Issued to Universal Display on Aug. 25 for "Organic electroluminescent materials and devices" (New Jersey Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,874, issued on Aug. 25, was assigned to Universal Display Corp. (Ewing, N.J.). "Organic electroluminescent materials and devices" was inven... Read More


US Patent Issued to Dart NeuroScience on Aug. 25 for "Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors" (California Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,875, issued on Aug. 25, was assigned to Dart NeuroScience LLC (Dallas). "Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors" was... Read More


US Patent Issued to SCHRODINGER on Aug. 25 for "Cyclic compounds and methods of using same" (California, New Jersey, New York, Oregon Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,876, issued on Aug. 25, was assigned to SCHRODINGER INC. (New York). "Cyclic compounds and methods of using same" was invented by Sayan Mon... Read More


US Patent Issued to Kymera Therapeutics on Aug. 25 for "Protein degraders and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,877, issued on Aug. 25, was assigned to Kymera Therapeutics Inc. (Watertown, Mass.). "Protein degraders and uses thereof" was invented by N... Read More


US Patent Issued to Janssen Pharmaceutica on Aug. 25 for "Tricyclic pyrimidines as cyclin-dependent kinase 7 (CDK7) inhibitors" (French, American Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,878, issued on Aug. 25, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium). "Tricyclic pyrimidines as cyclin-dependent kinase 7 (CD... Read More


US Patent Issued to VANDERBILT UNIVERSITY on Aug. 25 for "Quinazoline-4(3H)-one derivatives as negative allosteric modulators of metabotropic glutamate receptor 2" (Tennessee Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,715,879, issued on Aug. 25, was assigned to VANDERBILT UNIVERSITY (Nashville, Tenn.). "Quinazoline-4(3H)-one derivatives as negative allosteric... Read More